Clinical Trials by Condition

Browse actively recruiting studies by medical condition. All data updated daily from ClinicalTrials.gov.

Don't see your condition?

Search any condition in our full trial finder — over 400,000 studies indexed.

Search All Trials →

New to clinical trials? Read our complete guide before you start searching.

How to Find Clinical Trials →

Oncology

Breast Cancer
Trials testing targeted therapies, immunotherapy, and novel chemotherapy regimens.
Lung Cancer
Studies for NSCLC, SCLC, and rare lung malignancies including new immunotherapy combinations.
Prostate Cancer
From hormone therapy advances to novel targeted agents and radiopharmaceuticals.
Colorectal Cancer
Colon and rectal cancer trials including immunotherapy and precision medicine approaches.
Ovarian Cancer
PARP inhibitor, immunotherapy, and combination trials for ovarian malignancies.
Melanoma
Checkpoint inhibitors, targeted therapies, and adjuvant trials for skin cancer.
Leukemia
CAR-T, bispecific antibodies, and novel agents for acute and chronic leukemia.
Non-Hodgkin's Lymphoma
Cell therapy, antibody-drug conjugates, and combination regimen trials.
Pancreatic Cancer
Immunotherapy combos, targeted agents, and early detection biomarker studies.
Bladder Cancer
Checkpoint inhibitors, intravesical therapies, and neoadjuvant treatment trials.
Liver Cancer
Targeted therapies, immunotherapy, and locoregional treatment studies for HCC.

Metabolic & Cardiovascular

Type 2 Diabetes
Trials studying novel insulin therapies, GLP-1 agonists, and lifestyle interventions.
Heart Disease
Coronary artery disease and cardiovascular studies including device and drug trials.
Heart Failure
Studies for HFrEF, HFpEF, and advanced heart failure management.
Obesity
Weight management trials from GLP-1 receptor agonists to bariatric interventions.
Hypertension
New drug classes, renal denervation, and digital health interventions for blood pressure.
Atrial Fibrillation
Catheter ablation, anticoagulation, and wearable-based early detection trials.
Stroke
Clot-retrieval tech, neuroprotective agents, and rehabilitation robotics.
Chronic Kidney Disease
SGLT2 inhibitors, renoprotective agents, and improved dialysis technology trials.

Neurology & Mental Health

Alzheimer's Disease
Disease-modifying therapy trials, including amyloid-targeting and tau-directed approaches.
Parkinson's Disease
Neuroprotective, symptomatic, and surgical intervention studies.
Multiple Sclerosis
Disease-modifying therapies, remyelination approaches, and progressive MS trials.
Depression
Novel antidepressants, ketamine derivatives, TMS, and psychotherapy combination studies.
Epilepsy
Next-gen anti-seizure meds, neurostimulation devices, and gene therapy trials.
ADHD
Novel non-stimulant medications, digital therapeutics, and neurofeedback studies.
Anxiety Disorders
Novel anxiolytics, psychedelic-assisted therapy, and digital CBT approaches.
Bipolar Disorder
Mood stabilizers, atypical antipsychotics, and digital monitoring tool trials.
Schizophrenia
Next-gen antipsychotics, cognitive remediation, and digital therapeutics studies.
PTSD
MDMA-assisted therapy, novel pharmacotherapies, and technology-based interventions.
OCD
Novel serotonergic agents, glutamate modulators, and neuromodulation studies.
Migraine
CGRP-targeted therapies, neuromodulation devices, and preventive treatment trials.
Autism Spectrum Disorder
Behavioral interventions, oxytocin studies, and social skills therapy trials.

Autoimmune & Inflammatory

Rheumatoid Arthritis
Biologic and small-molecule trials for moderate-to-severe RA.
Crohn's Disease
Biologic, small-molecule, and dietary intervention trials for IBD.
Asthma
Biologic therapies, bronchial thermoplasty, and inhaler studies for all severities.
Lupus
New biologics and small molecules to reduce flares and prevent organ damage.
Psoriasis
Next-gen biologics, oral small molecules, and topical therapies targeting immune pathways.
Ulcerative Colitis
Advanced biologics, JAK inhibitors, and fecal microbiota transplantation trials.
Osteoarthritis
Disease-modifying agents, regenerative therapies, and pain management trials.

Respiratory & Pulmonary

COPD
New bronchodilators, anti-inflammatory agents, and pulmonary rehab approaches.
Cystic Fibrosis
CFTR modulators, gene therapy, and anti-infective treatment trials.
Sleep Apnea
New device therapies, surgical approaches, and pharmacological treatments.

Digestive & Metabolic

Irritable Bowel Syndrome
Microbiome therapies, gut-brain axis treatments, and new pharmacological agents.
Celiac Disease
Enzyme therapies, immune modulators, and gluten desensitization trials.
Hepatitis C
Pan-genotypic antivirals, retreatment strategies, and long-term outcomes studies.

Women's Health & Pain

Endometriosis
Non-hormonal treatments, GnRH antagonists, and minimally invasive surgical trials.
Fibromyalgia
Novel pain modulators, non-pharmacological interventions, and combination therapies.
Scoliosis
Bracing innovations, surgical techniques, and growth modulation studies.

Blood & Genetic Disorders

Sickle Cell Disease
Gene therapy (CRISPR), novel pain management, and disease-modifying treatments.
ALS
Gene silencing, neuroprotective compounds, and stem-cell therapy trials.

Eye & Sensory

Glaucoma
Neuroprotective agents, new surgical devices, and sustained-release drug delivery trials.

Infectious Disease

COVID-19
Long COVID, antiviral, and vaccine booster studies.